Experienced in Intrauterine Device Insertion

Dr. Amanda L. Jackson

Gynecologic Oncology | Oncology | Obstetrics and Gynecology
University Of Cincinnati Physicians Company LLC
68 Cavalier Blvd, 
Florence, KY 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Experienced in Intrauterine Device Insertion
University Of Cincinnati Physicians Company LLC
68 Cavalier Blvd, 
Florence, KY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Amanda Jackson is a Gynecologic Oncologist and an Oncologist in Florence, Kentucky. Dr. Jackson is rated as an Experienced provider by MediFind in Intrauterine Device Insertion. Her top areas of expertise are Endometrial Cancer, Cervical Cancer, Ovarian Cancer, Hysterectomy, and Intrauterine Device Insertion. Dr. Jackson is currently accepting new patients.

Her clinical research consists of co-authoring 43 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gynecologic Oncology
Oncology
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in RI
Hospital Affiliations
Christ Hospital
University Of Cincinnati Medical Center, LLC
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Health
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY LLC
68 Cavalier Blvd, Florence, KY 41042

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies
NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies
Enrollment Status: Recruiting
Publish Date: September 05, 2025
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2025
Intervention Type: Other, Drug, Procedure, Biological
Study Drugs: Carboplatin, Paclitaxel, Pembrolizumab
Study Phase: Phase 3
A Phase 1b/2 Open-Label Trial of Tisotumab Vedotin (HuMax®-TF-ADC) Monotherapy and in Combination With Other Agents in Subjects With Recurrent or Stage IVB Cervical Cancer
A Phase 1b/2 Open-Label Trial of Tisotumab Vedotin (HuMax®-TF-ADC) Monotherapy and in Combination With Other Agents in Subjects With Recurrent or Stage IVB Cervical Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drugs: Tisotumab Vedotin, Bevacizumab, Pembrolizumab, Carboplatin
Study Phase: Phase 1/Phase 2
A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody-Drug Conjugate (ADC), in Patients With Advanced Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) and Endometrial Cancers
A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody-Drug Conjugate (ADC), in Patients With Advanced Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) and Endometrial Cancers
Enrollment Status: Completed
Publish Date: August 20, 2025
Intervention Type: Drug
Study Drug: STRO-002
Study Phase: Phase 1
A Randomized, Double-Blind, Phase 3 Trial of Maintenance with Selinexor/ Placebo After Combination Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer
A Randomized, Double-Blind, Phase 3 Trial of Maintenance with Selinexor/ Placebo After Combination Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 20, 2025
Intervention Type: Drug
Study Phase: Phase 3
An Open-Label, Multi-Center Patient Access Program of Olaratumab for the Treatment of Soft Tissue Sarcoma
An Open-Label, Multi-Center Patient Access Program of Olaratumab for the Treatment of Soft Tissue Sarcoma
Enrollment Status: Approved_for_marketing
Publish Date: December 16, 2024
Intervention Type: Drug
Safety Study of Bintrafusp Alfa in Combination With Other Anti-cancer Therapies in Participants With Locally Advanced or Advanced Cervical Cancer (INTR@PID 046)
Safety Study of Bintrafusp Alfa in Combination With Other Anti-cancer Therapies in Participants With Locally Advanced or Advanced Cervical Cancer (INTR@PID 046)
Enrollment Status: Completed
Publish Date: March 08, 2024
Intervention Type: Drug, Radiation
Study Drugs: Bintrafusp Alfa, Carboplatin, Paclitaxel, Bevacizumab, Cisplatin
Study Phase: Phase 1
A Phase II, Multicenter, Open Label Study of Bintrafusp Alfa (M7824) Monotherapy in Participants With Advanced, Unresectable Cervical Cancer With Disease Progression During or After Platinum-Containing Chemotherapy
A Phase II, Multicenter, Open Label Study of Bintrafusp Alfa (M7824) Monotherapy in Participants With Advanced, Unresectable Cervical Cancer With Disease Progression During or After Platinum-Containing Chemotherapy
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Bintrafusp Alfa
Study Phase: Phase 2
A Single Arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer
A Single Arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer
Enrollment Status: Completed
Publish Date: July 25, 2023
Intervention Type: Drug
Study Drug: Tisotumab Vedotin
Study Phase: Phase 2
View 8 Less Clinical Trials

43 Total Publications

Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability.
Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability.
Journal: Gynecologic oncology
Published: June 11, 2025
Similar Doctors
Advanced in Intrauterine Device Insertion
Dr. Laura T. Broxterman
Obstetrics and Gynecology
Advanced in Intrauterine Device Insertion
Dr. Laura T. Broxterman
Obstetrics and Gynecology

Christ Hospital Medical Specialists LLC

5885 Harrison Ave, Suite 3100, 
Cincinnati, OH 
 (11.5 miles away)
513-922-6666
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Laura Broxterman is an Obstetrics and Gynecologist in Cincinnati, Ohio. Dr. Broxterman has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in Intrauterine Device Insertion. Her top areas of expertise are Female Genital Sores, Vaginal Bleeding Between Periods, Vitiligo, Vaginal Cysts, and Intrauterine Device Insertion. Dr. Broxterman is currently accepting new patients.

Advanced in Intrauterine Device Insertion
Dr. Christine Pennesi
Obstetrics and Gynecology | Pediatrics
Advanced in Intrauterine Device Insertion
Dr. Christine Pennesi
Obstetrics and Gynecology | Pediatrics
3333 Burnet Avenue, Mlc 2026, 
Cincinnati, OH 
 (11.6 miles away)
513-636-9400
Languages Spoken:
English
See accepted insurances

Christine Pennesi is an Obstetrics and Gynecologist and a Pediatrics provider in Cincinnati, Ohio. Dr. Pennesi is rated as a Distinguished provider by MediFind in Intrauterine Device Insertion. Her top areas of expertise are Kuster Syndrome, Mayer-Rokitansky-Kuster-Hauser Syndrome, Mullerian Aplasia, Intrauterine Device Insertion, and Oophorectomy.

Advanced in Intrauterine Device Insertion
Dr. Lesley L. Breech
Obstetrics and Gynecology | Adolescent Medicine
Advanced in Intrauterine Device Insertion
Dr. Lesley L. Breech
Obstetrics and Gynecology | Adolescent Medicine

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (11.7 miles away)
513-636-4200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lesley Breech is an Obstetrics and Gynecologist and an Adolescent Medicine provider in Cincinnati, Ohio. Dr. Breech is rated as a Distinguished provider by MediFind in Intrauterine Device Insertion. Her top areas of expertise are Vaginal Agenesis, Turner Syndrome, Hydrocele, Intrauterine Device Insertion, and Oophorectomy. Dr. Breech is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jackson's expertise for a condition
ConditionClose
View All 12 Distinguished Conditions
View All 23 Advanced Conditions
View All 56 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile